DOCSLIB.ORG

Noninvasive Ventilation with Helium–Oxygen Mixture in Hypercapnic

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Noninvasive Ventilation with Helium–Oxygen Mixture in Hypercapnic Abroug et al. Ann. Intensive Care (2017) 7:59 DOI 10.1186/s13613-017-0273-6 REVIEW Open Access Noninvasive ventilation with helium– oxygen mixture in hypercapnic COPD exacerbation: aggregate meta‑analysis of randomized controlled trials Fekri Abroug1*, Lamia Ouanes‑Besbes1, Zeineb Hammouda1, Saoussen Benabidallah1, Fahmi Dachraoui1, Islem Ouanes1 and Philippe Jolliet2 Abstract When used as a driving gas during NIV in hypercapnic COPD exacerbation, a helium–oxygen (He/O2) mixture reduces the work of breathing and gas trapping. The potential for He/O2 to reduce the rate of NIV failure leading to intubation and invasive mechanical ventilation has been evaluated in several RCTs. The goal of this meta-analysis is to assess the efect of NIV driven by He/O2 compared to air/O2 on patient-centered outcomes in hypercapnic COPD exacerbation. Relevant RCTs were searched using standard procedures. The main endpoint was the rate of NIV failure. The efect size was computed by a fxed-efect model, and estimated as odds ratio (OR) with 95% confdence interval (CI). Additional endpoints were ICU mortality, NIV-related side efects, and the length and costs of ICU stay. Three RCTs fulflled the selection criteria and enrolled a total of 772 patients (386 patients received He/O2 and 386 received air/O2). Pooled analysis showed no diference in the rate of NIV failure when using He/O2 mixture compared to air/O2: 17 vs 19.7%, respectively; OR 0.84, 95% CI 0.58–1.22; p 0.36; I2 for heterogeneity 0%, and no publication bias. ICU mortality = 2 = was also not diferent: OR 0.8, 95% CI 0.45–1.4; p 0.43; I 5%. However, He/O2 was associated with less NIV-related adverse events (OR 0.56, 95% CI 0.4–0.8, p 0.001),= and a shorter= length of ICU stay (diference in means 1.07 day, 95% CI 2.14 to 0.004, p 0.049). Total hospital= costs entailed by hospital stay and NIV gas were not diferent:= − dif‑ − − = ference in means 279$, 95% CI 2052–1493, p 0.76. Compared to air/O2, He/O2 does not reduce the rate of NIV failure in hypercapnic= − COPD exacerbation.− It is, however,= associated with a lower incidence of NIV-related adverse events and a shortening of ICU length of stay with no increase in hospital costs. Keywords: COPD, Exacerbation, Acute respiratory failure, Noninvasive ventilation, Helium Background clinical and technological aspects of NIV (defning opti- Noninvasive ventilation (NIV) has become a standard of mal indications, selection of ventilators and interface, care in COPD patients with acute exacerbation requir- improvements in patient–ventilator synchrony) has been ing ventilatory support [1–4]. Avoiding tracheal intuba- associated with substantial advances in NIV success tion drastically reduces the rate of ventilator-associated rates, allowing a wide range of patients to be managed pneumonia (VAP), antibiotic use, the time spent under entirely by this technique, thereby minimizing the risk of mechanical ventilation, ICU length of stay, and associ- complications inherent to conventional invasive ventila- ated mortality [5–9]. Te sustained mastering of the tion [2, 8, 9]. Despite these advances, it is believed that an additional success margin is possible, leading to further reduction in the number of patients still in need of inva- *Correspondence: [email protected] 1 Intensive Care Unit, CHU Fatouma Bourguiba, Research Laboratory sive ventilation. One such area of potential progress is the LR12SP15, University of Monastir, 5000 Monastir, Tunisia gas used for ventilation [10–12]. Full list of author information is available at the end of the article © The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. Abroug et al. Ann. Intensive Care (2017) 7:59 Page 2 of 11 Compared to air–oxygen (air/O2), a mixture of helium administration, minimum NIV duration with a given and oxygen (He/O2) has been consistently shown to con- gas mixture during the frst 24 h, composition of the gas vey numerous benefcial efects in the setting of increased administered between NIV sessions (whether helium/ airway resistance owing to its lower density. Indeed, the O2 or air/O2), type of associated medications, and crite- lower density of helium enhances the transition from ria for primary and secondary endpoints. Disagreements a turbulent to a laminar fow, thereby reducing density- were resolved by consensus. dependent components of airway resistance within bron- Data were extracted to allow quality assessment of the chi with increased resistance, as is the case in COPD included studies. Te risk of bias tool from the Cochrane exacerbation [10–16]. Tese efects translate into a Handbook was used [18]. reduction in dynamic hyperinfation and a lower work of breathing [10, 15, 17]. Tese studies provide sound scien- Data synthesis tifc grounds to anticipate a reduction in NIV failure rate In this meta-analysis, the primary endpoint was the rate when using He/O2 instead of air/O2 in COPD exacerba- of NIV failure during the index ICU stay. Te second- tion requiring ventilatory support [10]. Tis hypothesis ary endpoints included the intubation rate per se as the has been tested in randomized controlled trials (RCTs). defnition of NIV failure was not uniform; in one study, Te aim of the present systematic review and meta- the failure rate was a composite of necessity of intuba- analysis is to compare the efect of He/O2 and air/O2 NIV tion and/or death without intubation during the ICU on patient-centered clinical outcomes. stay [19]. Additional endpoints were ICU mortality, the length of ICU stay, and the costs of ICU stay. Safety was Methods assessed through the number of serious adverse events Search strategy and study selection related to He/O2 mixture, and the number of episodes of Relevant studies were searched in MEDLINE, EMBASE, complication related to NIV. Te latter consisted of facial and Science Citation Index with the restriction of ran- skin necrosis, gastric distension, pneumothorax, and domized clinical trial for article type published up to nosocomial pneumonia. NIV failure was not considered September 20, 2016, with the following MeSH terms: an NIV adverse efect since it was counted separately as [“non-invasive ventilation” or “Bilevel”] AND [(“pulmo- the primary outcome. nary disease, chronic obstructive”[MeSH Terms] OR (“pulmonary”[All Fields] AND “disease”[All Fields] AND Statistical analysis “chronic”[All Fields] AND “obstructive”[All Fields]) OR For binary outcomes (NIV failure rate, intubation rate, “chronic obstructive pulmonary disease”[All Fields] OR mortality, NIV complications, and adverse efects of He/ “copd”[All Fields]) AND “exacerbation”[All Fields] AND O2 mixture), we reported the efect sizes estimates as [“heliox” or “helium–oxygen” or “helium”]. We have also odds ratios (ORs) with 95% confdence intervals (CIs). conducted a manual search in journals and contacted For the length of ICU stay, and the diference in costs authors of trials. of the total hospitalization per patient, results were expressed as diference of means and 95% CIs. Only two Study selection out of three included studies reported the total costs per We included all randomized controlled clinical tri- patient, which consisted of both the costs of hospital als designed to evaluate the efcacy and safety of NIV stay and those of the gas used for noninvasive ventila- using a mixture of helium and oxygen to ventilate COPD tion. Te frst study was a Swiss one [20], and expressed patients with acute hypercapnic respiratory failure. the expenses in US$, while the second was a multicenter Standard treatment (e.g., bronchodilators and antibiot- study and reported detailed costs in French patients rely- ics) had to be comparable in control and intervention ing on diagnosis-related group (DRG) tools [19]. In the arms. Patients included in these studies were adults aged latter, costs were expressed in euros, and converted to € 18 and older with COPD diagnosed on clinical criteria US$ (1 = 1.1386US$). and respiratory function tests. Statistical signifcance was set at p < 0.05 for hypoth- esis testing and p < 0.1 for heterogeneity testing. We Data extraction and study characteristics measured heterogeneity and expressed it as I2, with Two independent evaluators (FA and LOB) selected stud- suggested thresholds for low (I2 25–49%), moderate 2 2 = ies according to the inclusion criteria and extracted the (I = 50–74%), and high (I ≥ 75%) values. We used a following: type and baseline characteristics of included fxed-efect model which assumes that studies included patients, the criteria for NIV, type and composition in the meta-analysis should share a common efect size, of He/O2 mixture (78/22 or 65/35%), time to the frst since patients’ characteristics and the evaluated interven- NIV session and its duration, total duration of He/O2 tion are similar in all studies. To assess publication bias, Abroug et al. Ann. Intensive Care (2017) 7:59 Page 3 of 11 we visually examined the funnel plot for NIV failure and Quality assessment performed the Egger test of the intercept which uses pre- Te three studies were randomized, controlled, non- cision to predict the standardized efect. All statistical blinded studies. Te risk of bias regarding random tests were two-sided. sequence generation and allocation concealment was low Te meta-analysis was conducted using the Com- in the study by Maggiore et al. [21] and unclear in the prehensive Meta-Analysis (CMA) program version 2 remaining two.
Load more

Recommended publications
  • Vocal Cord Dysfunction JAMES DECKERT, MD, Saint Louis University School of Medicine, St
    Vocal Cord Dysfunction JAMES DECKERT, MD, Saint Louis University School of Medicine, St. Louis, Missouri LINDA DECKERT, MA, CCC-SLP, Special School District of St. Louis County, Town & Country, Missouri Vocal cord dysfunction involves inappropriate vocal cord motion that produces partial airway obstruction. Patients may present with respiratory distress that is often mistakenly diagnosed as asthma. Exercise, psychological conditions, airborne irritants, rhinosinusitis, gastroesophageal reflux disease, or use of certain medications may trigger vocal cord dysfunction. The differential diagnosis includes asthma, angioedema, vocal cord tumors, and vocal cord paralysis. Pulmo- nary function testing with a flow-volume loop and flexible laryngoscopy are valuable diagnostic tests for confirming vocal cord dysfunction. Treatment of acute episodes includes reassurance, breathing instruction, and use of a helium and oxygen mixture (heliox). Long-term manage- ment strategies include treatment for symptom triggers and speech therapy. (Am Fam Physician. 2010;81(2):156-159, 160. Copyright © 2010 American Academy of Family Physicians.) ▲ Patient information: ocal cord dysfunction is a syn- been previously diagnosed with asthma.8 A handout on vocal cord drome in which inappropriate Most patients with vocal cord dysfunction dysfunction, written by the authors of this article, is vocal cord motion produces par- have intermittent and relatively mild symp- provided on page 160. tial airway obstruction, leading toms, although some patients may have pro- toV subjective respiratory distress. When a per- longed and severe symptoms. son breathes normally, the vocal cords move Laryngospasm, a subtype of vocal cord away from the midline during inspiration and dysfunction, is a brief involuntary spasm of only slightly toward the midline during expi- the vocal cords that often produces aphonia ration.1 However, in patients with vocal cord and acute respiratory distress.
    [Show full text]
  • Full Text (PDF)
    REVIEW COPD Physiological and clinical relevance of exercise ventilatory efficiency in COPD J. Alberto Neder1, Danilo C. Berton1,2, Flavio F. Arbex3, Maria Clara Alencar4, Alcides Rocha3, Priscila A. Sperandio3, Paolo Palange5 and Denis E. O’Donnell1 Affiliations: 1Respiratory Investigation Unit and Laboratory of Clinical Exercise Physiology, Queen’s University and Kingston General Hospital, Kingston, ON, Canada. 2Division of Respiratory Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. 3Pulmonary Function and Clinical Exercise Physiology, Respiratory Division, Federal University of Sao Paulo, Sao Paulo, Brazil. 4Division of Cardiology, Federal University of Minas Gerais, Belo Horizonte, Brazil. 5Dept of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy. Correspondence: J. Alberto Neder, 102 Stuart Street, Kingston, Ontario, Canada K7L 2V6. E-mail: [email protected] @ERSpublications Ventilatory efficiency is a key measurement for the interpretation of cardiopulmonary exercise testing in COPD http://ow.ly/1nsY307pbz8 Cite this article as: Neder JA, Berton DC, Arbex FF, et al. Physiological and clinical relevance of exercise ventilatory efficiency in COPD. Eur Respir J 2017; 49: 1602036 [https://doi.org/10.1183/13993003.02036- 2016]. ABSTRACT Exercise ventilation (V′E) relative to carbon dioxide output (V′CO2) is particularly relevant to patients limited by the respiratory system, e.g. those with chronic obstructive pulmonary disease (COPD). ′ − ′ High V E V CO2 (poor ventilatory efficiency) has been found to be a key physiological abnormality in symptomatic patients with largely preserved forced expiratory volume in 1 s (FEV1). Establishing an ′ − ′ association between high V E V CO2 and exertional dyspnoea in mild COPD provides evidence that exercise intolerance is not a mere consequence of detraining.
    [Show full text]
  • The Use of Heliox in Treating Decompression Illness
    The Diving Medical Advisory Committee DMAC, Eighth Floor, 52 Grosvenor Gardens, London SW1W 0AU, UK www.dmac-diving.org Tel: +44 (0) 20 7824 5520 [email protected] The Use of Heliox in Treating Decompression Illness DMAC 23 Rev. 1 – June 2014 Supersedes DMAC 23, which is now withdrawn There are many ways of treating decompression illness (DCI) at increased pressure. In the past 20 years, much has been published on the use of oxygen and helium/oxygen mixtures at different depths. There is, however, a paucity of carefully designed scientific studies. Most information is available from mathematical models, animal experiments and case reports. During a therapeutic compression, the use of a different inert gas from that breathed during the dive may facilitate bubble resolution. Gas diffusivity and solubility in blood and tissue is expected to play a complex role in bubble growth and shrinkage. Mathematical models, supported by some animal studies, suggest that breathing a heliox gas mixture during recompression could be beneficial for nitrogen elimination after air dives. In humans, diving to 50 msw, with air or nitrox, almost all cases of DCI can be adequately treated at 2.8 bar (18 msw), where 100% oxygen is both safe and effective. Serious neurological and vestibular DCI with only partial improvements during initial compression at 18 msw on oxygen may benefit from further recompression to 30 msw with heliox 50:50 (Comex therapeutic table 30 – CX30). There have been cases successfully treated on 50:50 heliox (CX30), on the US Navy recompression tables with 80:20 and 60:40 heliox (USN treatment table 6A) instead of air and in heliox saturation.
    [Show full text]
  • Respiratory Therapy Pocket Reference
    Pulmonary Physiology Volume Control Pressure Control Pressure Support Respiratory Therapy “AC” Assist Control; AC-VC, ~CMV (controlled mandatory Measure of static lung compliance. If in AC-VC, perform a.k.a. a.k.a. AC-PC; Assist Control Pressure Control; ~CMV-PC a.k.a PS (~BiPAP). Spontaneous: Pressure-present inspiratory pause (when there is no flow, there is no effect ventilation = all modes with RR and fixed Ti) PPlateau of Resistance; Pplat@Palv); or set Pause Time ~0.5s; RR, Pinsp, PEEP, FiO2, Flow Trigger, rise time, I:E (set Pocket Reference RR, Vt, PEEP, FiO2, Flow Trigger, Flow pattern, I:E (either Settings Pinsp, PEEP, FiO2, Flow Trigger, Rise time Target: < 30, Optimal: ~ 25 Settings directly or by inspiratory time Ti) Settings directly or via peak flow, Ti settings) Decreasing Ramp (potentially more physiologic) PIP: Total inspiratory work by vent; Reflects resistance & - Decreasing Ramp (potentially more physiologic) Card design by Respiratory care providers from: Square wave/constant vs Decreasing Ramp (potentially Flow Determined by: 1) PS level, 2) R, Rise Time (­ rise time ® PPeak inspiratory compliance; Normal ~20 cmH20 (@8cc/kg and adult ETT); - Peak Flow determined by 1) Pinsp level, 2) R, 3)Ti (shorter Flow more physiologic) ¯ peak flow and 3.) pt effort Resp failure 30-40 (low VT use); Concern if >40. Flow = more flow), 4) pressure rise time (¯ Rise Time ® ­ Peak v 0.9 Flow), 5) pt effort (­ effort ® ­ peak flow) Pplat-PEEP: tidal stress (lung injury & mortality risk). Target Determined by set RR, Vt, & Flow Pattern (i.e. for any set I:E Determined by patient effort & flow termination (“Esens” – PDriving peak flow, Square (¯ Ti) & Ramp (­ Ti); Normal Ti: 1-1.5s; see below “Breath Termination”) < 15 cmH2O.
    [Show full text]
  • Training Objectives for a Diving Medical Physician
    The Diving Medical Advisory Committee Training Objectives for a Diving Medicine Physician This guidance includes all the training objectives agreed by the Diving Medical Advisory Committee, the European Diving Technology Committee and the European Committee for Hyperbaric Medicine in 2011. Rev 1 - 2013 INTRODUCTION The purpose of this document is to define more closely the training objectives in diving physiology and medicine that need to be met by doctors already fully accredited or board-certified in a clinical speciality to national standards. It is based on topic headings that were originally prepared for a working group of European Diving Technology Committee (EDTC) and the European Committee of Hyperbaric Medicine (ECHM) as a guide for diving medicine some 20 years ago by J.Desola (Spain), T.Nome (Norway) & D.H.Elliott (U.K.). The training now required for medical examiners of working divers and for specialist diving medicine physicians was based on a EDTC/ECHM standard 1999 and subsequently has been enhanced by the Diving Medical Advisory Committee (DMAC), revised and agreed in principle by DMAC, EDTC and ECHM in 2010 and then ratified by EDTC and ECHM in 2011. The requirements now relate to an assessment of competence, the need for some training in occupational medicine, the need for maintenance of those skills by individual ‘refresher training’. Formal recognition of all this includes the need to involve a national authority for medical education. These objectives have been applied internationally to doctors who provide medical support to working divers. (Most recreational instructors and dive guides are, by their employment, working divers and so the guidance includes the relevant aspects of recreational diving.
    [Show full text]
  • A Review of the Use of Heliox in the Critically Ill
    Special review A Review of the use of Heliox in the Critically Ill T. WIGMORE, E. STACHOWSKI Intensive Care Unit, Westmead Hospital, Westmead, NEW SOUTH WALES ABSTRACT Heliox, a mix of oxygen and helium, has a number of potential medical applications resulting from its relatively lower density. This paper reviews the physics underlying its utility and considers the evidence for its use. While there are studies that support its role, particularly in patients with exacerbations of asthma and chronic obstructive pulmonary disease (COPD), the data are inconclusive. (Critical Care and Resuscitation 2006; 8: 64-72) Key words: Heliox, helium, airway obstruction, asthma, chronic obstructive pulmonary disease Helium was discovered in 1868 by the French astro- a given pressure difference. Clinically this can be utilis- nomer Pierre-Jules-Cesar Janssen during a spectro- ed to assist patients who suffer from airway narrowing. scopic study of a total solar eclipse in India. It was named later the same year by the British astronomer Table 1. Physical properties of pure gases at RTP Joseph Norman Lockyer and chemist Sir Edward (298 degrees Kelvin and 1 atmosphere pressure) Frankland, the name derived from helios, the Greek for Density Viscosity Thermal sun. It is an inert gas present in the atmosphere (ρ) (η) conductivity (0.00052%) and was used initially in airships and Kg/m3 microPoise W/m K balloons. Today, most commercial helium is recovered from Air 1.184 184.33 0.025 natural gas using a cryogenic separation process, foll- owing which it is refined and liquefied. Liquid helium is Carbon 1.811 148.71 0.017 shipped from the production site to various storage Dioxide facilities worldwide before being distributed in the Helium 0.166 197.61 0.14 gaseous form into cylinders for on-site use.
    [Show full text]
  • EMS DIVISION 23.1 Rev. 07/31/2020 PROTOCOL 23 WATER RELATED INCIDENTS
    PROTOCOL 23 WATER RELATED INCIDENTS A. Introduction “Drowning is the process of experiencing respiratory impairment from submersion / immersion in liquid” The word Drowning, should be used to refer to a person who drowned (death) or to a person who was rescued (fatal drowning or non-fatal drowning.) Water Rescue is the process of removing someone from the water in which dangerous conditions are present but the victim shows no signs of respiratory impairment. General Care 1. Initial assessment/Care Protocol 1. 2. Administer 15 L/min Oxygen via NRB mask. 3. Maintain normal body temperature to protect against hypothermia. B. Drowning EMR/BLS 1. Consider concurrent trauma and manage accordingly Protocol 21. 2. Consider insertion of I-gel with NG Tube (Lifeguards only) Procedure 49 and Procedure 12. 3. Determine important history from the patient or bystanders which includes: a) Duration of submersion b) Water temperature c) Any possibility of seizure activity d) Any associated drug or alcohol use e) How the patient entered the water 4. All non-fatal drowning victims must be transported to the closest appropriate facility for evaluation, regardless of how well they may seem to have recovered. Delayed death or complications due to pulmonary edema or aspiration pneumonia are common. ALS 5. Consider insertion of an NG/OG Procedure 12. EMS DIVISION 23.1 Rev. 07/31/2020 PROTOCOL 23 WATER RELATED INCIDENTS 6. Treat dysrhythmias per specific protocols. Consider hypoxia as a primary cause of the dysrhythmias. C. Decompression Sickness/Air Embolism EMR/BLS 1. Evaluate for specific signs and symptoms: a) Pain (primarily joint pain) b) Altered level of consciousness c) Generalized numbness or confusion d) Weakness or paralysis e) External or diagnosed internal bleeding f) Extreme vertigo 2.
    [Show full text]
  • Commercial Diving Physical Examination
    Commercial Diving Physical Examination To the Applicant / Student: Attached are the forms and instructions for a commercial diving physical examination. One of the most important requirements for acceptance as a student in the Professional Certificate in Marine Technology at National University and to become a commercial diver is a thorough physical examination in accordance with Association of Diving Contractors International standards. As a commercial diver, it is a personal responsibility to always have a current physical exam. A current physical exam must have been completed within the last year and there must be no physical maladies which would preclude you from diving or making hyperbaric exposures. Although the commercial diving physical examination can be done by any licensed physician; it is always best to have the physical examination done by a physician who is trained in diving medicine or hyperbaric medicine. Attached is a list of physicians in Los Angeles and San Diego who are approved to conduct diving examinations. You must have the physical examination completed including the laboratory testing (which can take several weeks) prior to the beginning of the program. The cost of the examination can vary and supporting laboratory fees can range from $275 to $600 dollars or more depending on if the physician finds the need to run additional tests. You are personally required to provide the following forms completed and signed by the doctor: The attached National University Polytechnic Institute letter stating that you have passed the physical examination and are cleared for work as a diver and for hyperbaric exposures. The attached ADCI form (Medical History and Physical Examination) completed and signed by yourself and the physician.
    [Show full text]
  • Model of Thermal Comfort in the Hyperbaric Facility
    POLISH MARITIME RESEARCH 1(68) 2011 Vol 18; pp. 37-44 10.2478/v10012-011-0006-y Model of thermal comfort in the hyperbaric facility Anna Majchrzycka, Ph. D. West Pomeranian University of Technology, Szczecin ABSTRACT The paper discusses the mathematical model of thermal comfort in the hyperbaric facility. Based on human thermal balance and thermal comfort conditions the comfort equation for the hyperbaric environment was derived. The comfort equation enables to calculate all those combinations of the diver’s activity, clothing (thermal insulation, moisture permeation factor) and environmental variables (temperature, pressure, composition, relative humidity and velocity of the breathing gas and mean radiant temperature), which would create thermal comfort in the hyperbaric environment. The paper presents also the solution of thermal comfort equation for dives up to the depth of g = 590 m, with helium-oxygen and hydrogen-oxygen breathing mixture, as well as the comfort diagrams. Keywords: comfort temperature; human balance; hyperbaric environment INTRODUCTION with experimental breathing mixtures containing the other inert gases: neon, argon [5]. Saturation diving is the diving operation that enables man Helium and hydrogen causes certain thermal problems to live and work in the sea-going deep dive systems or to be related to dangerous cooling of the divers. This is due to the trained in the land-based hyperbaric complexes for a long time. high thermal conductivity and specific heat of helium and Advanced diving technique requires an optimal breathing gas hydrogen. Therefore, comfort temperature in the hyperbaric to be selected. The use of air as the breathing gas is limited environment increases with the total pressure of gas and should because of oxygen toxicity and narcotic effect of nitrogen be maintained at a level higher than that in atmospheric air [5, 14, 15].
    [Show full text]
  • Precision Flow® Heliox Instructions for Use | Vapotherm
    Precision Flow® Heliox Instructions For Use Table of Contents Page Symbols 3 Section 1 Indications, Warnings and Cautions 4 Section 2 Overview 6 Section 3 Principles of operation 7 Section 4 Controls, displays & connections 8 Section 5 Modes of operation 11 Section 6 Initial assembly 12 Section 7 Setting up 13 Section 8 Adjustments 17 Section 9 Connecting to patient 18 Section 10 Operating guidelines 19 Section 11 Changing the disposable patient circuit 20 Section 12 Alarms 21 Section 13 Shut down 24 Section 14 Routine maintenance 24 Section 15 Cleaning and disinfection 25 Section 16 Specifications 26 Appendix: Audio Tone Characteristics 28 Software modes 29 EMC Guidance 30 Precision Flow® Heliox Packaging contains: Precision Flow® Heliox Unit Instructions For Use Quick Reference Guide Power Cord O2 Sensor cell Heliox & Oxygen Inlet Connectors US ONLY- Heliox and Oxygen Hoses Quick Set Up Sticker (English speaking countries only) Delivery Tube clip Page 2 3200003 Rev. B (EN) Symbols Vapotherm Inc. has declared that this product conforms with the European Council Directive 93/42/EEC Medical Device Directive when it is used in 0297 accordance with the instructions provided in the Instructions For Use. This symbol indicates that the waste of electrical and electronic equipment must not be disposed as an unsorted municipal waste and must be collected separately. Please contact an authorized representative of the manufacturer for information concerning the decommissioning of your equipment. Some Vapotherm accessories contain DEHP [Di-(2-Ethylhexyl) Phthalate] which is the most frequently used plasticizer to add flexibility to medical tubing. The medical tubing is intended for the transport of medical breathing gases and not for the storage of substances that have chemical extraction properties.
    [Show full text]
  • Diving Physics and "Fizzyology"
    Phys Diving Physics and "Fizzyology" Introduction Like all animals, human beings need oxygen in order to survive. When we breathe, we extract oxygen from the air, and use that oxygen for metabolism, which is how we convert the food we eat into useable energy to do the things that we do. One of the by-products of metabolism is carbon dioxide; whenever we exhale, we are getting rid of the carbon dioxide that our bodies produce. The main purpose of breathing, therefore, is to provide our bodies with oxygen, and rid our bodies of carbon dioxide. We humans are terrestrial (land-dwelling) mammals, and as such, our lungs are designed to breathe gas. Unlike fishes, we have no gills, so we cannot breathe water. Therefore, the first problem we must overcome to explore the underwater realm is a means to provide breathing gas. However, if this were the only barrier humans must overcome to enter the sea, we would have long-ago discovered most of the mysteries of the ocean. All we would need to remain underwater indefinitely would be a long tube going to the surface -- a huge snorkel -- through which we could breathe. Unfortunately, there is another problem we must over come when descending to the depths -- a problem with far more complex and difficult consequences. That problem is pressure. Pressure Have you ever wondered why nobody makes snorkels that are ten, or twenty, or a hundred feet long? The answer becomes obvious as soon as you try to breathe through a snorkel when your body is more than two or three feet (~1 meter) beneath the surface of the water.
    [Show full text]
  • Diving and Hyperbaric Medicine
    Diving and Hyperbaric Medicine The Journal of the South Pacific Underwater Medicine Society (Incorporated in Victoria) A0020660B and the European Underwater and Baromedical Society Volume 42 No. 3 September 2012 HBOT does not improve paediatric autism Diver Emergency Service calls: 17-year Australian experience Methods of monitoring CO2 in ventilated patients compared Australasian Workshop on deep treatment tables for DCI ‘Bubble-free’ diving – do bent divers listen to advice? Diving-related fatalities in Australian waters in 2007 ISSN 1833 3516 Print Post Approved ABN 29 299 823 713 PP 331758/0015 Diving and Hyperbaric Medicine Volume 42 No. 3 September 2012 PURPOSES OF THE SOCIETIES To promote and facilitate the study of all aspects of underwater and hyperbaric medicine To provide information on underwater and hyperbaric medicine To publish a journal and to convene members of each Society annually at a scientific conference SOUTH PACIFIC UNDERWATER EUROPEAN UNDERWATER AND MEDICINE SOCIETY BAROMEDICAL SOCIETY OFFICE HOLDERS OFFICE HOLDERS President President Mike Bennett <[email protected]> Peter Germonpré <[email protected]> Past President Vice President Chris Acott <[email protected]> Costantino Balestra <[email protected]> Secretary Immediate Past President Karen Richardson <[email protected]> Alf Brubakk <[email protected]> Treasurer Past President Shirley Bowen <[email protected]> Noemi Bitterman <[email protected]> Education Officer Honorary Secretary David Smart <[email protected]>
    [Show full text]